Kinetics of liver macrophages (Kupffer cells) in SIV-infected macaques  by Ahsan, Muhammad H. et al.
Virology 446 (2013) 77–85Contents lists available at ScienceDirectVirology0042-68
http://d
n Corr
Compar
Fax: 1 9
E-mjournal homepage: www.elsevier.com/locate/yviroKinetics of liver macrophages (Kupffer cells) in SIV-infected macaques
Muhammad H. Ahsan, Amy F. Gill, Xavier Alvarez, Andrew A. Lackner, Ronald S. Veazey n
Tulane National Primate Research Center, Tulane University School of Medicine, 18703 Three Rivers Road, Covington, LA 70433, USAa r t i c l e i n f o
Article history:
Received 1 March 2013
Returned to author for revisions
3 April 2013
Accepted 22 July 2013
Available online 19 August 2013
Keywords:
Liver
SIV
HIV
T cell
Immunology
Mucosal Immunology22/$ - see front matter & 2013 Elsevier Inc. A
x.doi.org/10.1016/j.virol.2013.07.026
espondence to: Tulane National Primate Rese
ative Pathology, 18703 Three Rivers Road, Cov
85 871 6510.
ail address: rveazey@tulane.edu (R.S. Veazey).a b s t r a c t
Since the liver drains antigens from the intestinal tract, and since the intestinal tract is a major site of
viral replication, we examined the dynamics of liver macrophages (Kupffer cells) throughout SIV
infection. Absolute numbers of Kupffer cells increased in the livers in acute infection, and in animals
with AIDS. Signiﬁcantly higher percentages of proliferating (BrdU+) Kupffer cells were detected in acute
infection and in AIDS with similar trends in blood monocytes. Signiﬁcantly higher percentages of
apoptotic (AC3+) Kupffer cells were also found in acute and AIDS stages. However, productively infected
cells were not detected in liver of 41/42 animals examined, despite abundant infected cells in gut and
lymph nodes of all animals. Increased rates of Kupffer cell proliferation resulting in an increase in Kupffer
cells without productive infection indicate SIV infection affects Kupffer cells, but the liver does not
appear to be a major site of productive viral replication.
& 2013 Elsevier Inc. All rights reserved.Introduction
Regardless of the route of transmission, the mucosal immune
system in general, and the gastrointestinal system in particular, are
central to the pathogenesis of HIV infection (Lackner et al., 2009).
Several critical events in SIV/HIV pathogenesis including viral ampli-
ﬁcation, and CD4+ T cell destruction occur in the intestinal tract
(Brenchley et al., 2004; Lackner et al., 2009; Mehandru et al., 2004;
Veazey et al., 1998). Since the liver is the major draining organ for
substances passing through the gut, it has a unique immunologic
environment. The liver contains one of the largest populations of
tissue macrophages (Crofton et al., 1978; Schmitt et al., 1990) and the
speciﬁc distribution of liver macrophages (Kupffer cells) within the
hepatic sinusoids allows them to be in close contact with circulating
cells from blood. Housset et al., suggested infection of Kupffer cells
(KC) may occur during primary HIV viremia (Housset et al., 1990a).
Primary cultures of human KC have also been shown to be permissive
for HIV infection (Schmitt et al., 1990). Moreover, HIV antigens or RNA
have been detected in liver cells of HIV-infected individuals, but the
percentage of virus positive cases, as well as the type and the number
of virus-containing cells reported varies substantially (Cao et al., 1992;
Hoda et al., 1991; Housset et al., 1990b, 1993). Further, studies by
Hufert et al., (1993) suggested that KC isolated from livers of AIDS
patients were only latently infected, and did not produce virus (Hufert
et al., 1993). Thus whether infection of liver macrophages/Kupffer cells
(KCs) occurs in vivo remains controversial (Hufert et al., 1993). Further,ll rights reserved.
arch Center, Division of
ington, LA 70433, USA.there is basically no information regarding the dynamics of lentivirus
persistence or replication in the liver in HIV infection.
Lentiviruses can infect and replicate in non-dividing cells of
monocyte/macrophage lineage (Verani et al., 2005). Macrophages
contribute to innate immune responses to pathogens and are at the
interface between innate and adaptive immunity. Thus, they play
a central role in control of infection, either by secreting cytokines,
directly destroying virus or infected cells, and/or activating either
innate or adaptive immune responses. However, direct infection of
macrophages with intracellular pathogens including HIV may impair
their function and alter cytokine production, resulting in chronic
inﬂammation and tissue damage. Unlike T cells, HIV infected
macrophages appear resistant to the cytopathic effects of the virus,
and the capacity of monocytes and macrophages to migrate to, and
survive within tissues for years makes them potential major
reservoirs for HIV-1 persistence (Herbein et al., 2002). Further, their
role as APC and/or a source of chemoattractant cytokines for CD4 T
cells may favor continual intercellular virus transmission. Therefore,
monocytes/macrophages may play a dual role in HIV infection,
contributing to both antiviral defenses and serving as targets for
infection and persistence (Herbein et al., 2002).
The aim of this study was to examine and compare the kinetics of
changes in absolute numbers of Kupffer cells in liver for comparison
with monocytes in peripheral blood throughout the course of SIV
infection. We also quantiﬁed the percentages of proliferating (BrdU+)
and apoptotic (AC3+) Kupffer cells in liver by ﬂow cytometry and
performed in situ hybridization to quantify SIV-infected Kupffer cells
throughout all stages of infection. Determining the kinetics of SIV
infection and turnover of Kupffer cells in vivo may provide important
information on the role of the liver in the pathogenesis of HIV
infection.
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Kupffer cells increase in the liver during SIV infection
Liver sections from all 42 infected and 8 uninfected macaques
were stained with mouse anti-human Ham56 antibody, which
labels tissue macrophages. Positive cells were manually counted
and quantiﬁed per mm2 of liver sections in a blinded fashion in 10
random ﬁelds for each section. Absolute numbers of Kupffer cells
markedly and signiﬁcantly increased in acutely infected macaques
and in those with AIDS, with mean values of 471741.6 (13 DPI),
3657102.7 (21 DPI) and 3977 47.2 (AIDS) vs 2177 45.0 (con-
trols) Ham56+ cells/mm2 liver (pr0.002, 0.03 and 0.01 respec-
tively) (Fig. 1B). Although there was a positive trend, numbers of
Kupffer cells in the liver at 8 DPI were not signiﬁcantly increasedFig. 1. (A): Triple-label confocal microscopy of liver macrophages (Kupffer cells) in vitro
co-express CD68 & Ham56 (CD68 with Alexa 488, green; Ham56 with Alexa 568, red; an
of liver in uninfected (control) and various stages of SIV infection as determined by immu
mm2 are detected after early SIV infection and in macaques with AIDS. *Indicates signiﬁc
(C and E) and blood (D and F) co-expressing CD163 (C and D) or CD14 (E and F) in acut
CD163 expression were detected on CD68+ cells in liver or blood due to SIV infection ((262733.4). Interestingly the chronic, asymptomatic SIV-infected
animals also did not show signiﬁcant increases over controls, with
means of 255724.9 in asymptomatic vs 2177 45.0 Ham56+ cells/
mm2 in controls (Fig. 1B). There were also no signiﬁcant changes in
percentages of CD68+ cells co-expressing CD163 or CD14 in liver
and blood in response to infection (Fig. 1C–F).
Changes in CD68+ Kupffer cells in liver and CD68+ monocytes in
peripheral blood
By ﬂow cytometry, absolute numbers of CD68+ macrophages
signiﬁcantly increased in acutely infected macaques with a mean
value of 26 (Control) vs 59 (acute) cells/mm2 of liver tissue
(pr0.0006). Absolute numbers of CD68+ macrophages in the AIDS
group also increased from 26 (control) to 40 (AIDS) cells/mm2 of livershowing co-localization of CD68 (green) and Ham56 (red), indicating Kupffer cells
d cell nuclei with Topro3). (B): Absolute numbers of Ham56+ Kupffer cells per/mm2
nohistochemistry for Ham56. Note signiﬁcant increases in Ham56+ Kupffer cells per
ant differences from controls (Po0.05). C–F: Percentages of CD68+ cells in the liver
e and chronic infection compared to controls. No signiﬁcant differences in CD14 or
C–F).
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numbers of CD68+monocytes also signiﬁcantly increased the blood in
AIDS macaques with a mean value of 0.1 (Controls) vs. 0.23 (AIDS)
cellsn103 /ul blood (pr0.02), whereas absolute numbers of CD68+
monocytes slightly decreased in acute group (Fig. 2B). Co-expression of
CCR5 and CXCR4 was also low on Kupffer cells (Fig. 2C–F), similar to
levels reported for intestinal macrophages (Meng et al., 2000; Shen
et al., 2011). In fact, Kupffer cells had a phenotype resembling those
reported for intestinal macrophages (Smith et al., 2005) including low
levels of CCR5/CXCR4 (Fig. 2C, E), and lower levels of CD4 (Fig. 2G), and
CD14 (Fig. 1E). There were no signiﬁcant changes in CXCR4 or CCR5Fig. 2. Absolute numbers of CD68+ liver macrophages (Kupffer cells) (A) and CD68+ bl
multiplying the percentages of CD68+ macrophages within the monocyte gate by ab
determined by multiplying absolute CD68+ cell counts in tissue sections by percentages
controls (Po0.05). C–F: Percentages of CD68+ cells co-expressing CXCR4 (C, D) and CCR5
in acute infection and AIDS compared to controls.expression on CD68+ monocyte/macrophages in blood or liver after
SIV infection (Fig. 2C–F).
Expression of CD163 and CD14 on Kupffer cells and monocytes
Expression of CD163 was examined in liver cell suspensions by
ﬂow cytometry and tissue sections by immunohistochemistry
(Fig. 3A, B). Interestingly, while 60–70% of CD68+ monocytes in
blood expressed CD163, only 20–30% of Kupffer cells expressed
CD163 in liver cell suspensions. However, using double label immu-
nohistochemistry for both Ham56 and CD163 on parafﬁn-embeddedood monocytes (B). Absolute numbers of monocytes in blood were determined by
solute monocyte counts from the CBC analysis. Macrophage counts in liver were
of CD68+ cells detected by ﬂow cytometry. nIndicates signiﬁcant differences from
(E and F) are shown for liver macrophages (C and E) and blood monocytes (D and F)
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Ham56 and CD163 (Fig. 3A). This suggested CD163 may have been
shed upon tissue processing. Since CD163 is rapidly shed upon
activation, and used as an in vivo marker of macrophage activation
(Burdo et al., 2011; Zanni et al., 2012) surface expression on
macrophages is likely very labile. The fact that cells were positive
for both Ham56 and CD163 in situ, but not in cell suspensions,
strongly suggests this discrepancy was an artifact associated with the
cell isolation process. In addition, only 15–20% of liver Kupffer cells
expressed CD14, whereas approximately 70–75% of blood monocytes
express CD14 (Fig. 1ce:bold>/ce:bold>). Since CD14 is also often shed
after activation, (Lien et al., 1998) we hypothesize that CD14 may be
lost in tissue processing, or that Kupffer cells are simply more
activated and express less CD14 than blood monocytes. Consistent
with this, higher percentages of CD68+ Kupffer cells expressed CD4
in acute infection, and in animals with AIDS (Fig. 2G). However CD68
+ blood monocytes exhibited higher expression of CD4 in the AIDS
group only (Fig. 2H). This suggests CD4 may be upregulated onFig. 3. (A, B): Confocal microscopy showing CD163+ and Ham56+ macrophages (A) an
Kupffer cells in the liver are Ham56+ and many are proliferating (BrdU+) during SIV inf
macrophages (C, D) and blood (E, F). Note there are signiﬁcant increases in the percentag
acute SIV infection and in macaques with AIDS. *Indicates signiﬁcant differences from cmacrophages upon activation or expressed on newly recruited tissue
macrophages, as previously suggested for intestinal macrophages
(Smith et al., 2005).
Proliferation and apoptosis of CD68+ Kupffer cells in liver and CD68+
monocytes in blood
In liver, percentages of CD68+ Kupffer cells in S-phase division
(BrdU+) were signiﬁcantly higher in acute infection and in AIDS
compared to controls (pr0.008 and pr0.02 respectively)
(Fig. 3D). Similarly, percentages of blood monocytes were signiﬁ-
cantly higher in acute infection and AIDS compared to controls in
blood (pr0.02 and pr0.003 respectively) (Fig. 3F).
Interestingly, similar positive trends were observed in the
percentages of CD163+ cells committed to apoptosis (AC3+) in
the liver. Percentages were signiﬁcantly higher in acutely infected,
and AIDS macaques compared to controls (pr0.0006 and pr0.01
respectively) (Fig. 3C). Percentages of CD163+ AC3+ monocytes ind proliferating (BrdU+) macrophages in liver (B). Note the majority of the CD163+
ection. C–F: Percentages of apoptotic (AC3+) and proliferating (BrdU+) CD68+ liver
es of proliferating/ BrdU+ CD68+ Kupffer cells in liver and blood monocytes in both
ontrols (Po0.05).
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infection compared to controls (Fig. 3E). There was a slight
increase in the percentage of CD163+ monocytes in the blood
committed to apoptosis (AC3+) in AIDS compare to controls, but
the difference was not signiﬁcant (Fig. 3E).
SIV RNA In-situ hybridization in liver, jejunum and colon, mesenteric
and axillary lymph node
To detect productively infected cells, both immunohistochem-
istry for SIV gag protein, and in-situ hybridization for SIV RNA was
performed on liver of all 42 SIV infected macaques. However, SIV-
infected cells were only detected in the liver of one animal with
clinical AIDS (BE65) (Fig. 4A). Further, most infected cells in this
macaque had a lymphocyte morphology, with very rare infected
cells resembling Kupffer cells. Positive (Fig. 4B) and negative
controls were used to conﬁrm the sensitivity of both techniques.
To conﬁrm reactivity of the in situ probe, sensitivity, and infection
of other lymphoid tissues in individual macaques, SIV in-situ
hybridization was performed on four additional tissues including
jejunum, colon, mesenteric and axillary lymph nodes of all 42
infected macaques. Viral RNA was detected in all four tissues of all
animals during acute and AIDS stages conﬁrming the animals had
high numbers of infected cells in lymphoid and mucosal tissues,
but not in the liver (data not shown). In acute infection, the
highest numbers of virus-infected cells were detected in mesen-
teric lymph nodes and lamina propria of the jejunum, despite
absence of viral RNA in liver tissue. In colon, most virus-infected
cells were found in the organized lymphoid tissues (data not
shown).Discussion
Since the advent of anti-retroviral therapy (ART), liver disease
has become the leading non-AIDS related cause of death in HIV
patients (Price and Thio, 2010). However, the effects of HIV
infection alone on the liver, especially in acute infection, are
essentially unknown. Prior to the era of antiretroviral therapy
(ART), the most common causes of liver dysfunction in HIV-
infected patients were opportunistic infections and AIDS-related
neoplasms (Price and Thio, 2010). Since ART, most descriptions of
liver pathology are associated with ART, medications, alcohol use,
or co-infection with various hepatitis viruses (Price and Thio,
2010). Thus, the effects of HIV infection alone on the liver are
difﬁcult to distinguish due to these confounding variables, making
the SIV macaque model invaluable for examining the effects of
retroviral infection alone on the liver.Fig. 4. SIV In-situ hybridization for SIV RNA in liver of one macaque with AIDS (A). N
Productively infected cells (viral RNA) were only detected in the liver of this one animal fr
animal (B).The macrophage is a common target cell for essentially all
lentiviral infections including HIV/SIV (Housset et al., 1993; Verani
et al., 2005). Interestingly, recent studies have shown that
increased monocyte/macrophage turnover is a key predictor of
SIV disease progression and AIDS (Hasegawa et al., 2009). The
Kupffer cells of the liver are the largest population of resident
macrophages in the body and efﬁciently phagocytose translocated
microbial products originating from the gut (Crofton et al., 1978).
Here we show that absolute numbers of Ham56+ Kupffer cells
markedly and signiﬁcantly increased in the livers of SIV infected
macaques by 13 and 21 DPI, and in animals with AIDS. Similar
trends were observed by ﬂow cytometry using CD68 to detect
Kupffer cells in the liver and blood monocytes. There were
signiﬁcantly higher numbers of CD68+ Kupffer cells in liver of
acutely infected macaques and higher numbers of CD68+ mono-
cytes in blood of animals with AIDS. Moreover there were
signiﬁcantly higher percentages of proliferating (BrdU+) CD68+
Kupffer cells in the liver of acutely infected macaques and in
animals with AIDS, and similar trends were observed in blood
monocytes. There were also signiﬁcantly higher percentages of
CD163+ Kupffer cells in the liver committed to apoptosis (AC3+)
during acute and AIDS stages of SIV infection. Increased percen-
tages of CD163+ monocytes committed to apoptosis (AC3+) were
detected in blood in acute infection. Combined, increased rates of
Kupffer cell proliferation and apoptosis indicate there is marked
turnover of monocytes/macrophages in the liver similar to what
has been described in lymphoid organs (Hasegawa et al., 2009).
However, in the liver this results in a net increased number of
Kupffer cells at least during acute and AIDS stages of SIV infection.
While numbers of Kupffer cells/mm2 in the liver may be increased,
increased turnover may result in a smaller percentage of mature,
fully functional Kupffer cells.
Localization of Kupffer cells within hepatic sinusoids allows
contact with circulating cells in blood. Beach et al., suggested
infection of Kupffer cells may occur during primary HIV viremia
(Beach et al., 1992). Primary cultures of human Kupffer cells have
been shown to be permissive for both HIV (Schmitt et al., 1990)
and SIV (Schmitt et al., 1990). HIV antigens or RNA have been
detected in liver cells of HIV- infected individuals, but the
percentage of virus-positive cases, as well as the type and the
number of virus-containing cells varies substantially (Cao et al.,
1992; Hoda et al., 1991; Housset et al., 1990b, 1993; Hufert et al.,
1993). Other studies suggest the liver may be a major organ for
clearing SIV particles from the circulation (Zhang et al., 2002).
However, Hufert et al., demonstrated that Kupffer cells isolated
from livers of AIDS patients were only latently infected, and did
not produce virus (Hufert et al., 1993), which is consistent with our
RNA results.ote abundant infected cells (dark brown) mostly with a lymphocyte morphology.
om the 42 examined. Positive controls included lymph node sections from the same
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hybridization detected infected cells in the liver of only one animal
(BE65, AIDS animal), despite the fact viral RNA was detected in gut
and lymphoid tissues of all SIV-infected animals examined using
the same techniques. Other than an extended duration of time
between infection and the onset of AIDS (1071 days) there was
nothing unusual about this animal compared to the other infected
animals (Table 1). This suggests the liver is not a major reservoir
for SIV, at least not for replicating virus in vivo. Although we did
detect increased apoptosis and proliferation indicating increased
turnover, the net result was an increase in Kupffer cells throughout
infection. This does not rule out the possibility that there may be
low level infection (beyond the limits of detection by in situ
hybridization) or latent infection of Kupffer cells in the liver. Since
the liver is a highly vascularized tissue containing abundant
peripheral blood cells within the sinusoids that could not be
removed from these samples, we did not attempt RT-PCR for viral
RNA or DNA on these samples, as we would not be able to
discriminate infection of blood monocytes/lymphocytes and liver
Kupffer cells in cell suspensions.
Prior studies have suggested the liver is a major site of viral
clearance in early SIV infection (Zhang et al., 2002). However, we
could not detect productively infected cells in the liver of maca-
ques in early infection. Since the liver contains a vast network of
sinusoids containing blood, previous studies using radiolabelled
viruses may have overestimated the amount of virus actually
within liver tissue versus the circulation. Alternatively, virus may
be cleared through the liver in degradative pathways that do not
allow viral integration and/or replication in Kupffer cells, which
could result in bonaﬁde clearance of virus in the liver, yet without
productive infection. For example, Kupffer cells may attach and
even phagocytize virions, yet destroy them before integration.
Alternatively, Kupffer cells may inhibit inﬂammation, preventing
viral replication within local lymphocytes or even autologous
replication.
In summary, these data indicate that there is increased turn-
over of liver macrophages (Kupffer cells) resulting in a net increase
in total numbers of Kupffer cells in response to SIV infection.
However, these cells show no evidence of productive infection
in vivo. Clearly, additional studies need to be performed in both
SIV and HIV infection in vivo, but the data here suggest Kupffer
cells proliferate in response to infection, and may play a major role
in SIV clearance, without being productively infected.Material and methods
Animals, virus and BrdU
A total of 50 male and female rhesus macaques (Macaca
mulatta) between 3 and 20 years of age housed at the Tulane
National Primate Research Center were used to quantify Kupffer
cells in liver, and monocytes in peripheral blood. Levels of plasma
viremia and CD4+ T cell counts in blood are shown in Table 1. All
animals were maintained in accordance with the standards of the
American Association for Accreditation of Laboratory Animal Care,
and all studies were reviewed and approved by the Tulane
Institutional Animal Care and Use Committee.
Macaques were infected with SIVmac251 by the intravenous
(IV) route for acute studies, and either the intra-vaginal (INVG) or
intra-rectal (IR) route for chronic infection studies. Although it is
conceivable some differences may have been attributed to differ-
ent routes of inoculation, we elected to use intravenous infection
especially in the early timepoints to ensure virus reached the liver
in these early timepoints. Mucosal inoculation is relatively inefﬁ-
cient, and in very early infection (day 8, 10, etc.) plasma viremiaoften cannot be detected after mucosal exposure. However, the
number of transmitted variants, and likely the numbers of viruses
entering the host differs between animals intravenously and
mucosally infected (Fennessey and Keele, 2013), and the effects
this may have had on the effects observed on Kupffer cells here is
not known.
For immunohistochemistry and quantitative image analysis of
tissue sections, macaques were divided into four groups; controls,
(uninfected, n¼8); acute infection from 7–21 days post-
inoculation (DPI; n¼18); chronic, yet asymptomatic infection
(n¼7); and chronic infection with deﬁnitive signs of AIDS
(n¼17). For some analyses, the acute group was further divided
into 7–10 DPI (n¼9), 13 DPI (n¼5), or 21 DPI (n¼4).
For ﬂow cytometry, livers were collected and processed imme-
diately upon necropsy from 22 macaques, which were divided into
three groups; controls (uninfected, n¼8); acute (7–21 days post-
inoculation), DPI (n¼7); and AIDS (n¼7). Acutely infected animals
were euthanized for tissue collection on 7, 10, 13 and 21 DPI.
Animals with AIDS were euthanized between 414 and 1071 DPI.
For in vivo tracking of cell proliferation, animals were intra-
peritoneally inoculated with bromodeoxy-uridine (BrdU) 24 s
prior to euthanasia and tissue collection.
Tissue collection and analysis
Whole blood samples were stained using a whole blood lysis
protocol as previously described (Veazey et al., 2003). For analysis of
liver leukocytes, single cell suspensions were prepared, using mod-
iﬁcations of a previously described procedure for intestinal tissues
(Veazey et al., 1997). Brieﬂy, 3–5 g liver tissue were minced with
razor blades, and incubated with 1 mM EDTA in Hanks balanced salt
solution for 30 min with rapid shaking (300 RPM) at 37 1C, followed
by 2 sequential 30 min incubations in RPMI containing 20 U/ml
collagenase (Type II, Sigma) with rapid shaking at 37 1C. After each
incubation, liver tissues were further disrupted by gently pipetting
5 to 10 times with a 16-g feeding needle, pelleted (400 g, 7 min), and
supernatants discarded and media replaced. At the end of these
incubations, cell pellets were resuspended and ﬁltered through nylon
mesh and layered over a 35%/60% bilayer isotonic Percoll density
gradient and centrifuged at 1000 g for 30 min. The interface between
the 35% and 60% Percoll layers were collected, washed, and adjusted
to 107cells/ml. For ﬂow cytometry, 100 cells/ml. For f 6 cells) were
stained with appropriately diluted concentrations of monoclonal
antibodies to CD68, CD163, and CD14, (BD Biosciences). Cells were
thenwashed and ﬁxed in 2% paraformaldehyde. For intracellular AC3
and BrdU staining, surface stained cells were washed and permea-
bilized with BD Cytoﬁx/Ctoperm buffer followed by staining with
activated caspase 3 (AC3) or a BrdU Flow Kit (BD Biosciences)
according to the manufacturer's instructions. Samples were acquired
on FACS Aria ﬂow cytometer (Becton Dickinson) within 24 h of
ﬁxation. Data was analyzed with Flowjo software (Tree Star Inc.) At
least 20,000 monocytes/macrophages were collected, and data was
analyzed by gating through monocytes/macrophages (identiﬁed by
back-gating on CD68) and then through cells of interest. Since CD68
is an intracellular lysosomal/endosomal-associated membrane glyco-
protein highly expressed and speciﬁc for monocytes and tissue
macrophages (Holness and Simmons, 1993), it was used as the major
marker for identifying Kupffer cells by ﬂow cytometry.
Quantitation of liver macrophages by immunohistochemistry and
ﬂow cytometry
Five μm sections of parafﬁn-embedded liver tissues were
stained for Ham56 and/or CD163 (macrophage markers) by
immunohistochemistry (IHC) as previously described (Borda
et al., 2008). Brieﬂy, slides were ﬁxed in xylene, rehydrated in
Table 1
Animals examined in this study.
Stage and animal# Sex Age Days after SIV Route of Inoc. CD4 counts Plasma viral load Diagnosis
Contro
AG71 F 11 NAa NAa 796 NAa NSLb
BB01 F 13 NAa NAa 2430 NAa NSLb
BE84 F 11 NAa NAa 2454 NAa NSLb
CC10 F 15 NAa NAa 1720 NAa NSLb
GN58 F 13 NAa NAa 480 NAa NSLb
GN70 F 10 NAa NAa 1091 NAa NSLb
GN74 F 13 NAa NAa 585 NAa NSLb
N483 F 16 NAa NAa 602 NAa NSLb
Acute
HI52 F 5 7 IVc 664 3,700,600 NSLb
AV63 F 4 8 IVc 463 24,310,900 Lymphoid hyperplasia
BA57 F 14 8 IVc 416 14,288,200 Lymphoid hyperplasia
HI53 F 7 8 IVc 325 3,555,700 Lymphoid hyperplasia
T108 F 13 8 IVc 653 57,314 Lymphoid hyperplasia
BV13 M 3 8 IVc 752 16,000,000 Lymphoid hyperplasia
AV91 M 14 10 IVc 472 157,190,000 Lymphoid hyperplasia
L880 M 11 10 IVc 212 7,000,000 Lymphoid hyperplasia
C419 M 20 10 IVc 383 11,000,000 NSLb
HI58 F 7 12 IVc 651 8,496,000 Lymphoid hyperplasia
HI63 F 7 12 IVc 438 24,310,900 Lymphoid hyperplasia
T139 M 7 13 IVc 355 3,200,000 Lymphoid hyperplasia
BA17 M 8 13 IVc 416 11,000,000 Lymphoid hyperplasia
M992 F 16 13 IVc 227 34,949,800 Lymphoid hyperplasia
AV85 F 8 21 IVc 670 230,000 Lymphoid hyperplasia
CB74 F 3 21 IVc 992 2,100,000 Lymphoid hyperplasia
BI58 M 3 21 IVc 558 12,000,000 Lymphoid hyperplasia
BN37 M 3 21 IVc 542 340,000 Lymphoid hyperplasia
Chronic
N998 F 10 180 INVGd 584 427,600 Lymphoid hyperplasia
R908 F 9 181 INVGd 653 4700 Lymphoid hyperplasia
CF35 M 5 91 IRe 546 121,680 Lymphoid hyperplasia
BV74 M 5 63 IRe 775 3111 Lymphoid hyperplasia
DI28 M 3 80 IRe 810 3064 Lymphoid hyperplasia
DL31 M 3 128 IRe 1332 54,500 Lymphoid hyperplasia
DB53 M 5 77 IRe 277 28,560 Lymphoid hyperplasia
DE09 M 4 76 IRe 1192 5088 Lymphoid hyperplasia
HG49 F 11 145 INVGd 184 104,945 Lymphoid hyperplasia
FK47 M 5 98 IRe 459 ND Lymphoid hyperplasia
FD49 M 5 110 IRe 318 ND Lymphoid hyperplasia
I553 F 11 646 IVc 21 1,895,400 AIDS; Pneumocystis inf.
R544 F 9 414 INVGd 190 1,700,000 AIDS: meningoencephalitis
AP53 F 6 63 IV 1127 4,100,000 AIDS; bacterial septicemia
DJ18 M 7 173 IVc 649 ND Lymphoid hyperplasia
HG45 F 14 148 IVc 191 964,152 AIDS; Pneumocystis inf.
HG58 F 11 283 INVGd 351 7074 AIDS; encephalitis
HG56 F 10 152 INVGd 339 19,522,700 AIDS; Gsstric lymphoma
FA14 F 9 1068 IVc 224 148,965 AIDS; Pneumocystis inf.
HI68 F 10 155 INVGd 22 8,076,200 AIDS: CMV infection
BD78 M 4 205 IVc 729 86,000 AIDS; Vasculitis, thrombosis
BE65 M 6 1071 IVc 288 480,000 AIDS: M avium inf
T196 M 7 230 IVc 270 750,000 AIDS; Pneumocystis inf.
FE53 M 4 140 IRe 469 343,459 AIDS; hepatitis, gastroenteritis
6Viremic but levels not determined at time of necropsy.
a Not applicable.
b No signiﬁcant lesions.
c Intravenous.
d Intravaginal.
e Intrarectal.
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formed by steam (495 1C) in 1 citrate buffer, pH 6.0 for 20 min,
and slides were washed with 1 tris buffered saline (TBS)
solution. A protein (DAKO Protein Blocker, Serum Free, Carpen-
teria, CAS) and peroxidase (Peroxidase Blocking Reagent, DAKO)
block was performed. After TBS wash, slides were incubated with
mouse anti-human Ham56 antibody (DAKO) or CD163 (clone
10D6, Novocastra Laboratories, Newcastle, UK) diluted in protein
blocker for 60 min followed by TBS wash and ampliﬁcation with a
biotinfree Peroxidase system with Mach3 probe and Polymer system
(Biocare; Concord, CA) per manufacturer's directions. As negative
controls, serial sections were processed identically using equiva-
lent concentrations of irrelevant primary antibodies of the
same isotype, and with slides incubated without primary or
secondary antibodies. For image analysis, Ham56+ macrophages
were detected by Cytomation Liquid DAB substrate chromogen
system (DAKO) after 5 min development. Tissues were washed
overnight in TBS, coverslipped, and imaged using a 20 objective
on a Leica DMLb microscope (Leica; Bannockburn, IL) with a Spot
M.H. Ahsan et al. / Virology 446 (2013) 77–8584Insight color camera utilizing Spot Imaging Software (Diagnostic
Instruments; Sterling Heights, MI). Each section was blindly
examined and 10 random non-touching ﬁelds (each with an area
of 0.28 mm2) were digitally imaged, and manually counted for
Ham56+ cells (macrophages) and reported as mean cells/mm2.
These absolute numbers of liver macrophages in sections
(Ham56+) were then used to estimate the percentages of all other
subsets detected in liver tissues by ﬂow cytometry as
described below.
Absolute numbers of Kupffer cells in liver were determined by
both image analysis of Ham56+ cells in tissue sections as above,
and ﬂow cytometry. Cell suspensions of liver were surface stained
with appropriately diluted directly conjugated monoclonal anti-
bodies against CD68 or Activated Caspase 3 (AC3)–FITC, CCR5 or
CD163-PE, CXCR4-PE-Cy5, HLA-DR-PE-Cy7, CD3-AL700, CD20-
APC-Cy7, CD14 Paciﬁc Blue, and CD4-Qdot655 for ﬂow cytometry.
For intracellular staining, surface stained cells were washed in
dPBS/BSA, ﬁxed, and permeabilized with BD Cytoﬁx/Ctoperm
buffer followed by intracellular staining for CD68-FITC and BrdU-
APC. Cells were washed again with BD Perm/Wash buffer and
samples were resuspended in BD stabilizing ﬁxative buffer and
acquired on FACS Aria ﬂow cytometer (Becton Dickinson) within
24 h of ﬁxation. Isotype-matched controls for each ﬂuorochrome
were included in all experiments. The CD4-Qdot655 was provided
by the NIH Nonhuman Primate Reagent Resource. All other
antibodies and reagents were purchased from BD Biosciences
Pharmingen (San Diego, CA). Stained samples were resuspended
in BD Stabilizing Fixative (BD Biosciences) and stored in the dark at
4 1C overnight and acquired on a BD FACS Calibur or FACSAria ﬂow
cytometer (Becton Dickinson) the next day. Data was analyzed
with Flowjo software (Tree star, Ashland, OR). At least 20,000
lymphocytes were collected and data was analyzed by gating
through lymphocytes and then through cells of interest. Percen-
tages of CD68+ cells within the macrophage gate were determined
by ﬂow cytometry, and used to determine absolute counts in liver
by comparison with immunohistochemistry results.
Cultured Kupffer cells from liver cell suspensions conﬁrmed
all Kupffer cells co-expressed CD68 and Ham56 (Fig. 1A). Thus,
percentages of CD68+ Kupffer cell subsets in liver cell suspensions
detected by ﬂow cytometry were assumed equivalent to Ham56+
cells in liver sections and were used as the baseline to quantify
further Kupffer cell subsets. For example, percentages of CD68+
cells co-expressing CD163, CD14, BrdU, or activated caspase 3
(AC3) detected by ﬂow cytometry were multiplied by absolute
numbers of Ham56+ cells measured in sections by IHC (above) to
determine absolute changes in cells in liver sections and expressed
as cells/mm2 liver tissue. In other words, if 5% of CD68+ cells
expressed CD4 by ﬂow cytometry, and there were 200 Ham56+
cells/mm2 liver section by IHC, then we could estimate that there
were ten (5% of 200 cells) CD68+CD4+ cells/mm2 liver.
Absolute numbers of monocytes in whole blood (WB) were
determined using a complete blood count (CBC) performed on
EDTA anti-coagulated blood collected prior to sacriﬁce on an
ADVIA 120 hematology analyzer (Bayer, Terrytown, NY). Percen-
tages of CD68+ macrophages within the WB monocyte gate
determined by ﬂow cytometry were multiplied by the absolute
monocyte count from the CBC to obtain absolute numbers of CD68
+ monocytes in blood. Percentages of CD68+ monocytes expres-
sing BrdU and AC3 were similarly converted to absolute counts
and expressed as 103 monocytes/μl blood.
SIV immunohistochemistry
Five μm sections of parafﬁn-embedded liver tissues were
stained for SIV gag protein using anti-P28 monoclonal anti-
body (Clone MX-0322, Microbix Biosystem Inc. Toronto, Ontario,Canada) by immunohistochemistry (IHC) as previously described
(Borda et al., 2004). Brieﬂy, slides were ﬁxed in xylene, rehydrated
in alcohol gradients, and ﬁnally water. Antigen retrieval was
performed by steam (495 1C) in 1X citrate buffer, pH 6.0 for
20 min, and slides were washed with 1X tris buffered saline (TBS)
solution. A protein (DAKO Protein Blocker, Serum Free, Carpen-
teria, CAS) and peroxidase (Peroxidase Blocking Reagent, DAKO)
block was performed. After TBS wash, slides were incubated with
mouse anti-P28 antibody (Microbix Biosystem Inc. Toronto,
Ontario, Canada) diluted (1:20) in protein blocker for 60 min
followed by TBS wash and ampliﬁcation with a biotin free
Peroxidase system (Biocare; Concord, CA) per manufacturer's
directions. P28+ cells were detected by Cytomation Liquid DAB
substrate chromogen system (DAKO) after 5 min development.
SIV in situ hybridization
SIV RNA In situ hybridization (ISH) was performed as previously
described (Borda et al., 2004; Wang et al., 2007). Formalin-ﬁxed,
parafﬁn-embedded liver sections were de-parafﬁnized overnight at
60 1C, then dehydrated by xylene washes followed by re-hydration
in an alcohol series ending in a ﬁnal distilled diethylpyrocarbonate
(DEPC) water rinse. All solutions were made with DEPC treated
water. Tissues were incubated in 0.2 M HCl followed by a saline-
sodium citrate (SSC) wash. Antigen retrieval by steam in 0.01 M
citrate buffer pH 6.0 was performed with a conventional micro-
wave. A 60 min pre-hybridization incubation was performed fol-
lowed by an overnight incubation at 45 1C in hybridization buffer
with SIV RNA digoxigenin labeled probe (Lofstrand Labs Limited;
Gaithersburg, MD) to detect SIV-infected cells. Short successive
washes in SSC were conducted on day two. Excess SSC was removed
and tissues were incubated in protein block (Serum Free Protein
Blocker, DAKO; Carpenteria, CA). Slides were incubated overnight
with appropriately diluted sheep Fab fragments of anti-digoxigenin
antibody (Roche Diagnostics; Indianapolis, IN) in dark humidiﬁed
chambers at 4 1C. Two post-hybridization buffer washes were
applied on day three. Controls included lymph node sections from
known positives and negatives, and hybridization with digoxigenin-
labeled sense RNA. The chromogen nitro blue tetrazolium chloride/
5-Bromo-4-chloro-3-indolyl phosphate (NBT-BCIP) (Roche) was
used to detect SIV infected cells. For RNA ISH, 3-h NBT-BCIP
incubation was performed. A blinded evaluation of random, non-
touching ﬁelds per tissue was performed. Sections were imaged
with a 20 objective using a Spot Insight color camera and Spot
Imaging Software (Diagnostic Instruments; Sterling Heights, MI).
Confocal microscopy
Confocal microscopy was performed using a Leica TCP SP2
confocal microscope equipped with three lasers (Leica Microsystems,
Exton, PA). Image J64 (v1.6; NIH, Bethesda, MD) and Adobe Photo-
shop (CS5.1; Adobe, San Jose, CA) was used to assign colors to the
four channels collected: HNPP/Fast Red, which ﬂuoresces red when
exposed to a 568-nm wavelength laser; Alexa 488 (Molecular
probes) ﬂuoresces green; Alexa 633 (Molecular Probes) appears blue;
and the differential interference contrast (DIC) image is gray scale.
The four channels were collected simultaneously. In some tissues the
nuclei was stained with To-pro3 (nuclear marker, Molecular Probes)
used at 1 mg/ml. Co-localization of antigens was demonstrated by the
addition of colors as indicated in ﬁgure legends.
Statistics
Statistical analysis was performed with a non-parametric Mann
Whitney U test using Graphpad Prism software (Graphpad
M.H. Ahsan et al. / Virology 446 (2013) 77–85 85software, San Diego, CA, USA). P values ofr0.05 were considered
signiﬁcant. All data are expressed as means7SEM.Financial support
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